QGEN Competitors & Alternatives
Compare Qiagen NV with similar stocks in the same industry
Diagnostics & Research
QGEN
Main Stock$42.50
Tradestie Score
49
Market Cap
$10.04B
P/E Ratio
21.6
Revenue Growth
0.0%
Analyst Upside
+8.4%
Top Competitors
37 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 52 | Compare |
|
RVTY
Revvity, Inc.
|
$124.31
|
$10.65B | 59.6 | 44 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.12
|
$9.33B | 62.1 | 51 | Compare |
|
CRL
Charles River Laboratories International, Inc.
|
$278.26
|
$8.39B | - | 42 | Compare |
|
BIO
Bio-Rad Laboratories, Inc.Class A
|
$369.32
|
$8.06B | 45.9 | 44 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$157.38
|
$7.81B | - | 49 | Compare |
|
RDNT
RadNet, Inc. Common Stock
|
$75.49
|
$6.00B | - | 61 | Compare |
|
BLLN
BLLN
|
$98.77
|
$4.65B | 138.7 | 48 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$18.37
|
$4.60B | 32.0 | 46 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$85.27
|
$3.26B | - | 36 | Compare |
More QGEN Analysis
Data updated: Sep 12, 2026 | Industry: Diagnostics & Research (SIC 2836)
37 stocks in this industry